Resmed Cdi revenue and financials
$31.78Change from previous close: −0.69%Absolute change: −$0.22
In the fiscal year ended June 2026, Resmed Cdi reported revenue of $5.65B (+9.85% year over year). Net income was $1.52B, a net margin of 26.9%.
Fiscal year ending in June. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +9.85%
- FY to Jun 2026 vs FY to Jun 2025
- Net income growth
- +8.75%
- FY to Jun 2026 vs FY to Jun 2025
- Net margin
- 26.9%
- FY to Jun 2025: 27.2%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | FY to Jun 2026 | FY to Jun 2025 | FY to Jun 2024 | FY to Jun 2023 | FY to Jun 2022 |
|---|---|---|---|---|---|
| Operating cash flow | 1,806 | 1,752 | 1,401 | 693 | — |
| Depreciation and amortization | 244 | 236 | 216 | 198 | — |
| Capital expenditure | -177 | -101 | -115 | -134 | — |
| Investing cash flow | -545 | -200 | -270 | -1,160 | — |
| Financing cash flow | -1,007 | -606 | -1,119 | 423 | — |
| Dividends paid | -350 | -311 | -282 | -258 | — |
| Share repurchases | -700 | -300 | -150 | 0.0 | — |
| Debt issued | 0.0 | 0.0 | 105 | 1,070 | — |
| Debt repaid | -10.0 | -40.0 | -835 | -405 | — |
| Effect of exchange rates | 6.2 | 25.8 | -1.7 | -2.1 | — |
| Net change in cash | 254 | 945 | 12.2 | -43.7 | — |
| Free cash flow | 1,629 | 1,651 | 1,286 | 559 | — |